(PharmaNewsWire.Com, December 21, 2017 ) According to the report Europe Next generation sequencing market, published by Market Data Forecast, the market was worth USD 0.96 billion by the end of 2015 and projected to reach USD 2.33 billion by 2020, at a CAGR of 19.3% from 2015 to 2020.
Next Generation Sequencing is a modern technology which assist in sequencing of DNA and RNA much more quickly and cheaply than the Sanger sequencing which transformed the study of genomics and molecular biology. This technique is also known as high throughput sequencing. Its arrival minimizes the requirement for fragment-cloning methods used in Sanger sequencing of genomes. Low cost, high accuracy and speed, and precise results even from low sample input are the main advantages NGS offers over Sangers sequencing method.
Europe Next Generation Sequencing (NGS) market: Drivers & Restraints Technological advancements in NGS platforms and it is emerging at a rapid pace, due to its increasing application in clinical diagnosis, increasing applications of NGS, growing partnerships & collaborations, speed, cost, and accuracy of the technology, efficient replacement of traditional technologies, increasing adoption of NGS among research laboratories and academic institutes, and the decline in the cost of sequencing are driving the growth of this market. However, interpretation of complex data, accuracy and standardization concerns in diagnostic testing, legal & ethical issues and the lack of skilled technical personnel are some of the key factors limiting the growth of the market.
Europe Next Generation Sequencing (NGS) market: Overview Next generation sequencing is used to execute various applications such as biomarker discovery, oncology studies, personalized medicine, agricultural & animal research, and others. The arrival of next generation sequencing technologies has brought noteworthy changes in the sequencing process by providing speed, flexibility and reduced sequencing cost over thousand folds. Next generation sequencing has streamlined nucleotide analysis and has widely replaced conventional tools of genomics, especially microarray efficiently.
Europe Next Generation Sequencing (NGS) market: Region-wise Outlook The Europe market has been geographically segmented into Germany, U.K, France, Spain, and Italy. After North America, Europe has the largest share in the market due to the technological advancements in the healthcare sector, government funding for translational research, and rising partnerships & agreements among market players.
Key Questions Answered What is the current and future Next Generation Sequencing market outlook in Europe? What trends are affecting the Europe market? What is the competitive landscape and market share of major players in the Next Generation Sequencing in Europe? What are the key, high growth markets that Next Generation Sequencing should expand into? Which market segments are growing the fastest? What are the unmet needs with the Next Generation Sequencing currently on the market? How will emerging technologies fulfil these unmet needs? What is physician perception and market outlook of Next Generation Sequencing? What are the challenges and barriers that have hindered widespread adoption of Next Generation Sequencing?
Europe Next Generation Sequencing (NGS) market: Key Players Key players in the Next generation sequencing market are Illumina Incorporated, Thermo Fischer Scientific, Life Sciences (Roche), Pacific Biosciences, Life Technologies Corp. (Thermo Fischer Scientific), Macrogen Inc., Partek Inc., Genomatix Software GmbH, Perkin Elmer inc.,GATC Biotech Ag, Agilent Technologies Inc., Biomatters Ltd., CLC Bio (Qiagen), BGI (Beijing Genomics Institute), Oxford Nanopore Technologies Ltd.,Pacific Biosciences, DNASTAR Inc., Knome Inc., Illumina Inc., and Qiagen N.V.
Reasons to buy Europe Next Generation Sequencing (NGS) Market Report: Regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Biotechnology Segment:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
